Dr. William E. Cohn is one of the leaders of the team of experts developing a total artificial heart that will deliver blood by means of continuous flow rather than pulsation. This research has grant support from the National Heart, Lung, and Blood Institute; the John S. Dunn Research Foundation; the Alexander Family Trust; and the McIngvale family Trust. This new artificial heart is smaller, less expensive, and predicted to be more reliable than previous generations of artificial hearts.
William E. Cohn currently has 80 active or pending patents for his inventions and is the founder or co-founder of five venture-backed life science startups.
In addition, Dr. Cohn is a venture partner at Santé Health Ventures, a venture capital firm focused on capitalizing early-stage life science technology.